Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study
Albert Hagège, Dominique P. Germain(Assistance Publique – Hôpitaux de Paris), Firas Jabbour(Heidelberg Academy of Sciences and Humanities), Philippe Charron(Inserm), A Millaire(Lille’s Cardiology Hospital), Caroline Etchecopar-Chevreuil(Hôpital Dupuytren), Thibaud Damy(Amyloidosis Foundation), Catherine Boucly(Hôpital Raymond-Poincaré), Patrice Prognon(Laboratoire COBRA), Éric Caudron(Université Paris-Sud), T.C.K. Tran(Erasmus MC), Raymond Roudaut(Hôpital Cardiologique du Haut-Lévêque)
Cited by 89
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k